Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/JSPR/Capital expenditures

Jasper Therapeutics, Inc. (JSPR) Capital expenditures

Jasper Therapeutics, Inc. (JSPR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to JSPR

Source: SEC XBRL filings · For reference only · Not investment advice

More JSPR financial trends

JSPR RevenueJSPR Net incomeJSPR Net marginJSPR Gross profitJSPR Gross marginJSPR Operating incomeJSPR Operating marginJSPR Operating cash flowJSPR Free cash flowJSPR Return on equityJSPR Stock buybacksJSPR Dividends paidJSPR Total assetsJSPR Total liabilitiesJSPR Shareholders’ equityJSPR overview →